Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolastin in Hospitalized COVID-19
NCT04495101Phase 2Completed
- Sponsor
- Grifols
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-1-proteinase inhibitor in coronavirus disease 2019 (COVID-19), sponsored by Grifols. Started Jul 2020; status: completed.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04495101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04495101.